Clinical Trials Logo

Clinical Trial Summary

Hypothesis: More than 80% of the participants (n=40) will complete the intervention at three month (intervention completion) and the six month follow-up (retention rate as feasibility). More than 70% of the participants will report high overall study satisfaction (acceptability) with the intervention and study. This pre-pilot will inform intervention and procedural refinements for the pilot. Hypothesis: Participants who receive the intervention (n=57) will report more skin cancer-related preventive behaviors (e.g., mean of summed score of sun protection behaviors such as use of sunscreen, etc.) at three month and six month follow-up compared to those in the control condition (n=57, who will receive general information about physical activity and nutrition).


Clinical Trial Description

Aim 1: The investigator will conduct individual interviews among key stakeholders such as health care providers and community leaders to plan a mobile skin cancer intervention among Hispanics. Data will be collected from individual interviews (n=10-12) among key stakeholders and triangulated with data from a funded pilot grant (focus groups and surveys with Hispanic community members) to gather information regarding Hispanics perceptions and behaviors related to skin cancer and suggestions for a WhatsApp intervention. Aim 2: Employing a user-centered approach to develop a WhatsApp intervention to promote skin cancer risk-reduction behaviors among Hispanics and encourage engagement in the intervention. Use an iterative qualitative (focus groups with Hispanics, n=32; individual interviews with key stakeholders e.g., health care providers and community leaders, n=10-12) process to incorporate input from Hispanics and relevant stakeholders to develop a mobile WhatsApp intervention that is theory- and culturally-guided. Aim 3: The investigators will evaluate the feasibility and acceptability of this mobile intervention in a single-arm pre-, post-test pilot study among at-risk Hispanics. Aim 4: Refine the intervention and conduct a pilot RCT (n = 114) using this mobile program among Hispanics at risk for skin cancer and assess the preliminary effects of the mobile intervention at 3-month (intervention completion) and 6-month follow-ups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05389332
Study type Interventional
Source Rutgers, The State University of New Jersey
Contact Zhaomeng Niu, PhD
Phone 509-339-3076
Email zhaomeng.niu@rutgers.edu
Status Recruiting
Phase N/A
Start date April 15, 2025
Completion date April 15, 2026

See also
  Status Clinical Trial Phase
Withdrawn NCT03282188 - REO13 Melanoma With of Without GM-CSF Phase 1/Phase 2
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Not yet recruiting NCT04968704 - Computer Modelling to Plan Surgical Reconstruction
Recruiting NCT03301493 - Genomic Testing and Resulting Medical Decisions
Terminated NCT04337931 - A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma Phase 2
Withdrawn NCT04127318 - Low-moderate Intensity Pedaling During Immunotherapy Administration N/A
Completed NCT04059588 - A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin Phase 1
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Terminated NCT00278018 - Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors Phase 1/Phase 2
Completed NCT00859768 - The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients N/A